Drug Approvals
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 1–12 of 739 articles
Quick answer
NovaPharmaNews Drug Approvals hub for FDA covers 739 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
FDA MRD guidance in multiple myeloma: what BD teams should track
Alembic Wins Tentative FDA Nod for First Generic Larotrectinib Capsules
FDA priority review advances belzutifan plus pembrolizumab in adjuvant RCC
FDA adds bemotrizinol to sunscreen rules, expanding U.S. UV filter options
Biotech coming of age: market analysis of a sector in transition
FDA approves Vepdegestrant (Veppanu) for ESR1-mutated breast cancer
Sensorion pivots to SENS-601 after Regeneron’s OTOF hearing loss advance
SLS Stock Jumps on Biotech Momentum as SELLAS Gains 25.10%
Medicare GLP-1 coverage 2026: Bridge program starts July 1
FDA Approves First Interchangeable Biosimilars to Simponi and Simponi Aria
FDA Drug Approval: What Approval Means for Pharma Marketing and BD
Vanda tradipitant update: FDA re-review extends to Dec. 5, 2025
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.